Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02768363
Title Randomized Controlled Trial of ProstAtak Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Advantagene, Inc.
Indications

prostate adenocarcinoma

Therapies

AdV-tk + Valacyclovir

Valacyclovir

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.